Abstract:Existing anticancer therapeutic modalities in clinical settings lack efficacy and fail to completely cure cancers. Clearly understandable and mechanistic approaches are inevitable to improve the efficiency of anticancer therapies. There is indestructible evidence that radioactive materials have been used in cancer therapies since 1890, but toxicities restrict their broad clinical utility. Preliminary studies explain a deeper understanding of radioactive material properties and its interaction with living organisms. Advanced characterization advocates discriminatory responses of radioactive materials to various materials invitro and in vivo models. This indicates that repurposing therapeutic strategies is indispensable. Contemporary innovative and integrated scientific environment has provided opportunity to forward attractive platforms for cancer radiotherapies. In recent years, the emerging concept of integration of nanotechnology and radiotherapies has energized the therapeutic outcomes in various preclinical models. Resurfacing the idea of transforming external radiotherapies into internal radiotherapies has become an interesting research area in cancer therapeutics. Initial evaluations indicate that stipulating nanoparticles with alpha emitters can show a landscaping route for their targeted anticancer activities. However, the interaction of various elements such as radionuclides with their carrier results in modified physical and chemical characteristics, which mandates the careful evaluation and selection of materials. Besides, dosimetry is also an important concern for radiotherapies due to its off-target toxicities and half-life radioactive elements. In view of these facts and recent updates on radiotherapies, this review provides a comprehensive and comparative overview of various types of radiotherapies and rationally compares their efficacy, advantages and disadvantages, and discusses various types of biomaterials and their perspective in radiotherapies. Further, this manuscript through light on assimilated approaches to reengineering radiotherapies. Also, it explores and discusses the narrative on targeted alpha radiotherapy and provides a comparison with other forms of radiotherapies. In general, this manuscript discusses the nanotechnology perspective of radiotherapies.

Analysis of the molecular alterations in cancer cells following nanotechnology-assisted targeted radiotherapy using Raman spectroscopy

Nanoscale Radiotheranostics for Cancer Treatment: From Bench to Bedside

Emerging Nanoradiosensitizers and Nanoradioprotectants for Enhanced Cancer Theranostics

Clinically Boosting Cancer Molecular Targeted Radioligand Therapies with Innovative Nanomaterials

Tailoring Radiotherapies and Nanotechnology for Targeted Treatment of Solid Tumors

Rational Design of Cancer-Targeted BSA Protein Nanoparticles As Radiosensitizer to Overcome Cancer Radioresistance

Bioorthogonal SERS Nanotags As a Precision Theranostic Platform for in Vivo SERS Imaging and Cancer Photothermal Therapy

Advances of Nanomedicine in Radiotherapy

Targeted Delivery of Nano-Radiosensitizers for Tumor Radiotherapy

Application of nanomedicine in radiotherapy sensitization

Label-Free Raman Spectroscopy Reveals Signatures of Radiation Resistance in the Tumor Microenvironment

Self-Reporting and Splitting Nanopomegranates Potentiate Deep Tissue Cancer Radiotherapy Via Elevated Diffusion and Transcytosis.

Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy

Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer

A Raman spectroscopic study of cell response to clinical doses of ionizing radiation

Radiosensitization With Nanoparticles Targeting to Mitochondria

Raman Reporter-Coupled Ag-Core@Au-Shell Nanostars for in Vivo Improved Surface Enhanced Raman Scattering Imaging and Near-Infrared-Triggered Photothermal Therapy in Breast Cancers

State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment

Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer

Self-Reporting and Splitting Nano-Pomegranates Potentiate Deep Tissue Cancer Radiotherapy via Elevated Diffusion and Transcytosis.

Recent advances in nanoscale targeted therapy of HER2-positive breast cancer